These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23282210)

  • 1. Discordance between EGFR expression and clinicopathologic parameters of colorectal adenocarcinoma in Taiwan.
    Tsai WC; Lin CK; Lee HS; Chen A; Nieh S; Yu CP; Wu CC; Jao SW; Jin JS
    Chin J Physiol; 2012 Oct; 55(5):352-60. PubMed ID: 23282210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.
    Kanavaros P; Stefanaki K; Valassiadou K; Vlachonikolis J; Mavromanolakis M; Vlychou M; Kakolyris S; Gorgoulis V; Tzardi M; Georgoulias V
    Med Oncol; 1999 Apr; 16(1):23-30. PubMed ID: 10382939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
    Gurzu S; Jung J; Mezei T; Pávai Z
    Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors.
    Menezes HL; Jucá MJ; Gomes EG; Nunes BL; Costa HO; Matos D
    Arq Gastroenterol; 2010; 47(2):141-7. PubMed ID: 20721457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
    Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
    Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of membranous epidermal growth factor receptor in colorectal adenocarcinoma and its correlation with clinicopathological features.
    Mohammadi G; Jamialahmadi K; Lary S; Ghaffarzadegan K
    Pak J Biol Sci; 2011 Mar; 14(5):357-62. PubMed ID: 21874828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression.
    Martín R; Nieto S; Santamaría L
    Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors.
    De Jong KP; Stellema R; Karrenbeld A; Koudstaal J; Gouw AS; Sluiter WJ; Peeters PM; Slooff MJ; De Vries EG
    Hepatology; 1998 Oct; 28(4):971-9. PubMed ID: 9755233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histochemical and immunohistochemical evidence of tumor heterogeneity in colorectal cancer.
    Zlatian OM; Comănescu MV; Roşu AF; Roşu L; Cruce M; Găman AE; Călina CD; Sfredel V
    Rom J Morphol Embryol; 2015; 56(1):175-81. PubMed ID: 25826503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of fascin-1 in advanced colorectal adenocarcinoma: tissue microarray analysis of immunostaining scores with clinicopathological parameters.
    Tsai WC; Chao YC; Sheu LF; Chang JL; Nieh S; Jin JS
    Dis Markers; 2007; 23(3):153-60. PubMed ID: 17473384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Epidermal Growth Factor Receptor in Colorectal Adenocarcinoma and its Correlation with Clinicopathological Factors.
    Nemanqani DM; Aftab K; Al-Malki SH; Al-Sufyani WM
    J Coll Physicians Surg Pak; 2018 Jul; 28(7):527-531. PubMed ID: 29950257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
    Lin MX; Wen ZF; Feng ZY; He D
    Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer - clinical and morphological aspects.
    Mogoantă SS; Vasile I; Totolici B; Neamţu C; Streba L; Busuioc CJ; Mateescu GO
    Rom J Morphol Embryol; 2014; 55(1):103-10. PubMed ID: 24715173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p16, p53, and Ki-67 in colorectal adenocarcinoma: a study of 356 surgically resected cases.
    Huh JW; Lee JH; Kim HR
    Hepatogastroenterology; 2010; 57(101):734-40. PubMed ID: 21033219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic significance of EGFR and Her-2/neu in colorectal adenocarcinomas.
    Kountourakis P; Pavlakis K; Psyrri A; Rontogianni D; Xiros N; Patsouris E; Pectasides D; Economopoulos T
    Cancer J; 2006; 12(3):229-36. PubMed ID: 16803682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
    Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
    Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.